SPL Set ID: 431ff2ef-567c-4b60-af43-f4da61febaad

1 drug(s) with this SPL Set ID

Open DailyMed details

Potassium Chloride POTASSIUM CHLORIDE
BLUEPOINT LABORATORIES FDA Rx Only

Potassium chloride extended-release capsules, USP, 10 mEq is an oral dosage form of microencapsulated potassium chloride containing 750 mg of potassium chloride USP equivalent to 10 mEq of potassium. Dispersibility of potassium chloride (KCl) is accomplished by microencapsulation and a dispersing agent. The resultant flow characteristics of the KCl microcapsules and the controlled release of K+ ions by the microcapsular membrane are intended to avoid the possibility that excessive amounts of KCl can be localized at any point on the mucosa of the gastrointestinal tract. Each crystal of KCl is microencapsulated by a process with an insoluble polymeric coating which functions as a semi-permeable membrane; it allows for the controlled release of potassium and chloride ions over an eight-to-ten-hour period. Fluids pass through the membrane and gradually dissolve the potassium chloride within the micro-capsules. The resulting potassium chloride solution slowly diffuses outward through the membrane. Potassium chloride extended-release capsules, USP, 10 mEq are electrolyte replenishers. The chemical name of the active ingredient is potassium chloride USP and the structural formula is KCl. Potassium chloride USP occurs as a granular crystalline powder. It is freely soluble in water and practically insoluble in ethanol. The inactive ingredients are, ethylcellulose, FD&C red #3, FD&C yellow # 6, gelatin, magnesium stearate, sodium lauryl sulfate, talc and titanium dioxide. The imprinting ink contains the following: black iron oxide, potassium hydroxide and shellac. Meets USP Dissolution Test 2.

← Back to search